by The Tutu Team | Mar 14, 2017 | Uncategorized
Author: Linda A. Johnson / Source: CTVNews The logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea on Saturday, Aug. 13, 2016. (AP / Ahn Young-joon) TRENTON, N.J. – U.S. regulators have approved a... by The Tutu Team | Oct 20, 2016 | Uncategorized
Before sunrise on February 22, 2013, Alexander Hardy, a Genentech vice president at the time, was already in his office. He was waiting to hear if a new medicine that he was hoping to launch was going to be approved by the U.S. Food and Drug Administration (FDA). He... by The Tutu Team | Oct 18, 2016 | Uncategorized
Roche Holding’s anti-PDL1 immunotherapy MPDL3280A, or atezolizumab, has received priority review status from the FDA as a treatment for patients with PD-L1-positive metastatic or locally advanced non-small cell lung cancer whose disease progressed with... 
by The Tutu Team | Jun 30, 2016 | Uncategorized
In a one-on-one interview Biden told us, “It can eliminate any unintended roadblocks in the way to making science and research more difficult”. Meanwhile, the Food and Drug Administration named Richard Pazdur, who currently oversees reviews of cancer drugs... 
by The Tutu Team | Jun 26, 2016 | Uncategorized
Source – Zen Gardner by Paul Fassa Apparently the left hand of this government doesn’t know what the right hand is doing, or more likely doesn’t want to know. With the easy prey of grabbing marijuana users in most states and locking them up in... 